| Advanced and Metastatic Breast Cancer |
1 |
1 |
| Breast Cancer |
0 |
0.99 |
| Hepatocellular Carcinoma |
0 |
0.72 |
| Cancer |
0 |
0.63 |
| Liver Metastases |
0 |
0.62 |
| Metastasis |
0 |
0.59 |
| Breast |
0 |
0.54 |
| COVID-19 |
0 |
0.51 |
| Genomic Medicine |
0 |
0.42 |
| Receptors |
0 |
0.29 |
| Aromatase Inhibitors |
0 |
0.2 |
| Estrogen |
0 |
0.2 |
| Tumor |
0 |
0.2 |
| Liver |
0 |
0.15 |
| Endocrine Therapy |
0 |
0.1 |
| Myocardial Infarction (MI) |
0 |
0.09 |
| Pneumonia |
0 |
0.09 |
| Acute Myocardial Infarction (MI) |
0 |
0.07 |
| Cerebral Hemorrhage |
0 |
0.07 |
| Hemoglobin A1c |
0 |
0.07 |
| Aspiration |
0 |
0.05 |
| Biomarker |
0 |
0.05 |
| Board Certification |
0 |
0.05 |
| Cerebrovascular Accident |
0 |
0.05 |
| Chemotherapy |
0 |
0.05 |
| Diarrhea |
0 |
0.05 |
| Genetics |
0 |
0.05 |
| Hemoglobin |
0 |
0.05 |
| Hemorrhage |
0 |
0.05 |
| Hospital |
0 |
0.05 |
| Hyperglycemia |
0 |
0.05 |
| Infarction |
0 |
0.05 |
| mTOR Inhibitor |
0 |
0.05 |
| NHS |
0 |
0.05 |
| Sepsis |
0 |
0.05 |
| Traumatic Brain Injury |
0 |
0.05 |